12.07.2015 Views

Measles, Mumps, and Rubella - Centers for Disease Control and ...

Measles, Mumps, and Rubella - Centers for Disease Control and ...

Measles, Mumps, and Rubella - Centers for Disease Control and ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Vol. 47 / No. RR-8 MMWR 45rubella-specific antibody levels that do not decline at the rate expected from passivetransfer of maternal antibody (i.e., the equivalent of a twofold decline in HI titer permonth). However, some infected infants may have low antibody levels because ofagammaglobulinemia or dysgammaglobulinemia.In some infants with CRS, rubella virus can persist <strong>and</strong> can be isolated from nasopharyngeal<strong>and</strong> urine cultures throughout the first year of life or longer (229 ).Children with CRS should be presumed infectious at least through the first year of lifeunless nasopharyngeal <strong>and</strong> urine cultures are negative <strong>for</strong> virus after age 3 months(230 ). Some authorities suggest that an infant who has CRS should be consideredinfectious until two cultures of clinical specimens obtained 1 month apart are negative<strong>for</strong> rubella virus (230 ). Precautions should be taken to ensure that infants with CRS donot cause additional rubella outbreaks. Specifically, all persons who have contact witha child with CRS (e.g., care givers, household contacts, medical personnel, laboratoryworkers) should be immune to rubella (Table 1) (see Documentation of Immunity <strong>and</strong>Routine Vaccination).<strong>Rubella</strong> Outbreak <strong>Control</strong>Outbreak control is important <strong>for</strong> eliminating CRS. Aggressive responses to outbreaksmay interrupt chains of transmission <strong>and</strong> can increase vaccination coverageamong persons who might not be protected otherwise. Although methods <strong>for</strong> controllingrubella outbreaks are evolving, the main strategy should be to define targetpopulations <strong>for</strong> rubella vaccination, ensure that susceptible persons within the targetpopulations are vaccinated rapidly (or excluded from exposure if a contraindication tovaccination exists), <strong>and</strong> maintain active surveillance to permit modification of controlmeasures as needed.<strong>Control</strong> measures should be implemented as soon as a case of rubella is confirmedin a community. This approach is especially important in any outbreak setting involvingpregnant women (e.g., obstetric-gynecologic <strong>and</strong> prenatal clinics). All persons atrisk who cannot readily provide laboratory evidence of immunity or a documentedhistory of vaccination on or after the first birthday should be considered susceptible<strong>and</strong> should be vaccinated unless vaccination is contraindicated (Table 1) (see Documentationof Immunity).<strong>Rubella</strong> Outbreaks in Schools or Other Educational InstitutionsAn effective means of terminating rubella outbreaks <strong>and</strong> increasing rates ofvaccination quickly is to exclude from possible contact persons who cannot providevalid evidence of immunity. Experience with measles outbreak controlindicates that almost all students who are excluded from school because theylack evidence of immunity quickly comply with vaccination requirements <strong>and</strong> arepromptly readmitted to school. Persons exempted from rubella vaccination <strong>for</strong>medical, religious, or other reasons should also be excluded from attendance.Exclusion should continue <strong>for</strong> 3 weeks after the onset of rash of the last reportedcase in the outbreak setting. Less rigorous approaches (e.g., voluntary appeals<strong>for</strong> vaccination) have not been effective in terminating outbreaks.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!